Epizyme CEO Robert Bazemore's 2019 pay rises 14% to $4.2M
Epizyme reports 2019 executive compensation
By ExecPay News
Published: April 17, 2020
Epizyme reported fiscal year 2019 executive compensation information on April 17, 2020.
In 2019, five Epizyme executives received on average a compensation package of $2.3M, a 16% increase compared to previous year.
Average pay of disclosed executives at Epizyme
Robert B. Bazemore Jr, Chief Executive Officer, received $4.2M in total, which increased by 14% compared to 2018. 49% of Bazemore's compensation, or $2.1M, was in option awards. Bazemore also received $409K in non-equity incentive plan, $593K in salary, $1.1M in stock awards, as well as $5.6K in other compensation.
For fiscal year 2019, the median employee pay was $302,723 at Epizyme. Therefore, the ratio of Robert B. Bazemore Jr's pay to the median employee pay was 14 to one.
Shefali Agarwal, Chief Medical Officer, received a compensation package of $2.9M, which increased by 44% compared to previous year. 43% of the compensation package, or $1.3M, was in option awards.
Paolo Tombesi, Chief Financial Officer, earned $2.2M in 2019.
Matthew Ros, Chief Strategy and Business Officer, received $2.1M in 2019, which increases by 21% compared to 2018.
Suzanne Fleming, Former Senior Vice President, Finance and Treasurer, earned $31K in 2019, a 96% decrease compared to previous year.
Related executives
Robert Bazemore
Epizyme
Chief Executive Officer
Paolo Tombesi
Epizyme
Chief Financial Officer
Suzanne Fleming
Epizyme
Former Senior Vice President, Finance and Treasurer
Matthew Ros
Epizyme
Executive Vice President, Chief Strategy and Business Officer
Shefali Agarwal
Epizyme
Executive Vice President, Chief Medical and Development Officer
You may also like
Source: SEC filing on April 17, 2020.